22nd Asian Conference on Clinical Pharmacy – 13-15 July 2023 – Haiphong, Vietnam

The YOLARX team will be present at the 22^nd Conference on Clinical Pharmacy (ACCP 2023), and will discuss the question “Is Applied Epidemiology Feasible in Clinical Pharmacy Practice?” on 15 July (10am) during the “Symposium 12: Clinical Pharmacy Services and Evaluation (2)”. If you would like to learn more, contact us: contact@yolarx.com. Read more

NASoP Annual (Virtual) Meeting – 07-08 November 2022

Prof. Moride, President and founder of YOLARX Consultants, presented “Opioids, how are we doing? Impact of opioids-related policies and RMMs on ADRs” at the North American Chapter of the International Society of Pharmacovigilance (NASoP) Annual (Virtual) Meeting on 08 November 2022 (08:00–09:50 AM). If you would like to learn more, contact us: contact@yolarx.com. Read more

DIA Canadian Annual Meeting – 18-19 October 2022 – Ottawa (Canada)

Prof. Moride, President and founder of YOLARX Consultants, presented at DIA Canada, “Key Considerations for Successful Risk Minimization” on 19 October 2022 (09:20–10:35 AM). If you would like to learn more, contact us: contact@yolarx.com.

Article “Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data” released in ‘Drugs – Real World Outcomes’ today

YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of the impact of the COVID-19 pandemic on the use of prescription opioids in Canada. Read more

21st Annual Meeting of the International Society of Pharmacovigilance (ISoP 2022) – Verona (Italy) – 20-23 September 2022

YOLARX attended ISoP’s 2022 Annual Meeting which took place from 20 to 23 September in Verona, Italy under the theme “A new Era of Pharmacovigilance: challenges and opportunities”.  Read more

38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2020, Copenhagen – Denmark, 24-28 August 2022

YOLARX participated at ICPE 2022 with 3 posters, 1 oral presentation, and 1 pre-conference course.   Read more

Article “Evaluation of interventions and policies on opioids in Canada: A mixed-methods descriptive study” released in ‘International Journal of Environmental Research and Public Health’ today

YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of “all components of the therapeutic risk minimization framework (i.e., intervention coverage, process indicators, health outcomes)” for opioids in Canada. Read more

DUPHAT – Dubai International Pharmaceuticals & Technologies Conference and Exhibition – 22-24 February 2022

Prof. Moride, president and founder of YOLARX Consultants, attended the 2022 DUPHAT, the biggest pharmaceutical event in the Middle East & Africa. She presented on the “Impact of the COVID-19 pandemic on risk management and risk minimization” as well as “New insights in therapeutic risk management, a focus on pharmacists’ role”.

20th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2021) – Muscat (Oman) – 08-10 November 2021

Prof. Moride, president and founder of YolaRx Consultants, will speak about “Risk management and minimization” presented in the session on “Integrating safety data and knowledge from different information sources” which will take place on Monday, November 8th, 17:00 – 18:30, UTC.

We are hiring: Research Associate in Pharmacoepidemiology

You would like to integrate into a company that is constantly evolving, to join a young and dynamic team and to take on new challenges? Consult our job openings and submit your application to: contact@yolarx.com. Read more

36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2020 – All Access, 16-17 September 2020

YOLARX attended the virtual conference “ICPE 2020 – All Access” with several posters and one oral presentation. If you’d like to hear more, please contact us at: contact@yolarx.com. Read more

12th Asian Conference on Pharmacoepidemiology (ACPE) – Kyoto (Japan) – 11-13 October 2019

Prof. Moride, president and founder of YolaRx Consultants, will present “A Delphi Study on the development of a risk proportionality framework for the selection of risk minimisation interventions in Asia” at the 12th ACPE conference in Kyoto, Japan on Saturday, 12th October 2019.

1st Society of Pharmacovigilance (ISOP) Israel International Symposium – Tel Aviv (Israel), 3 – 4 June 2019

Prof. Moride, president and founder of YolaRx Consultants, presented “THE OPIOID CRISIS: Chronic opioid use in a universal health care setting following the implementation of risk communication” at the 1^st ISOP Israel international symposium in Tel Aviv, Israel on Monday, 3rd of June, 2019.

8th Annual Bordeaux Pharmacoepi Festival – Bordeaux, France – 21-23 May 2019

The YOLARX team will be attending the 8^th Annual Bordeaux Pharmacoepi Festival in Bordeaux, France on May 21^st-23^rd 2019. If you’re interested in meeting on site, please send us an email at: contact@yolarx.com.

9th Pharmaceutical Care Conference – Muscat (Oman) – 4-6 February 2019

Prof. Moride, President of YOLARX Consultants, attended the 9^th Pharmaceutical Care Conference in Muscat. Prof. Moride presented on the pharmacovigilance analysis of product confusion errors and issues. Want to hear more about the conference? Send us an e-mail: contact@yolarx.com

Read more

Canadian Pharmacovigilance and Risk Management Strategies Conference – Oct. 29th, 2018 – Ottawa (Canada)

Prof. Moride, President and Founder of YOLARX Consultants, presented at the Canadian Pharmacovigilance and Risk Management Strategies Conference held in Ottawa on October 29^th, 2018. During this conference, Prof. Moride presented strategies and data sources to evaluate the effectiveness of risk minimization interventions for opioids. If you’d like to hear more, please contact us at: contact@yolarx.com

Read more

DIA Canadian Annual Meeting October 30th, 2018 – Ottawa (Canada)

Prof. Moride, President and Founder of YOLARX Consultants, presented at the DIA Canadian Annual Meeting on October 30^th, 2018 in Ottawa. Prof. Moride presented on the subject of the evaluation of the effectiveness of risk minimization activities.

Read more

NASoP 1st Annual Meeting 2018 – Cambridge (USA)

Prof. Moride, President of YOLARX Consultants, attended the first North American Chapter of the International Society of Pharmacovigilance (NASoP) held in Cambridge on November 2^nd, 2018. Hosted by Takeda, the theme was on Structured Benefit-Risk Assessment. Prof. Moride was part of the panel and presented on an Academic perspective. If you’re interested in learning more, please send us an email at: contact@yolarx.com

Read more

ISoP 18th Annual Meeting 2018- Geneva (Switzerland)

Prof. Moride, President of YOLARX Consultants, and Dr. Genaro Castillon, Medical Advisor, attended the ISOP 18^th Annual Meeting 2018 in Geneva. Want to hear more? Send us an email at:contact@yolarx.com

Read more